Psychedelics as Agents of Transformation: A Conversation with Psychiatrist Dr. Jennifer Guo, Director of Psychedelic Medicine at Mindful Health Solutions

There has been a renaissance of interest in the boundary-pushing, consciousness-altering medications for alleviation of suffering in psychiatric patients. Bipartisan in nature, and with a growing public interest from politicians and donors, this movement is spurred by a cultural shift away from the War on Drugs. Mainstream explorations and writings by the likes of Michael Pollan have raised public awareness of how psychedelics may work in treating Depression, Anxiety, and PTSD. Medicines such as ketamine, MDMA and psilocybin work in the brain by inducing neuroplasticity, lighting up the brain in a sense. This process can help patients confront deeply rooted traumas and modify their maladaptive reactions and responses in a variety of life situations. These groundbreaking treatments are provided in conjunction with psychotherapy and take place in calm and therapeutic settings, contrasting with the recreational use of these substances. Join Paul and Dr. Guo for a deep dive into this creative therapy -- an innovative tool and much in demand given the mental health crisis exacerbated by Covid.